Haemophilia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are male
- You have severe hemophilia A, meaning your Factor VIII levels are below 1%
- You are 16 years old or older
- You are currently taking either Factor VIII or emicizumab as a regular preventive treatment, and you plan to stay on that same treatment for the next 3 years
- You are willing and able to sign a consent form agreeing to take part
- You are willing to have joint ultrasound scans, a bone density scan (DEXA), and possibly give blood samples for research purposes
- You are willing to attend an initial visit and then 3 follow-up visits over 3 years
- You are willing to answer a phone survey about bleeding and safety every 3 months
Who may not be able to join:
- You have developed antibodies (called inhibitors) against Factor VIII above a certain level (confirm with trial site)
- You are unable to receive Factor VIII replacement therapy
- You have another bleeding disorder in addition to hemophilia A
- You have a rheumatological condition (such as arthritis) that affects your joints
- You have a known condition affecting your nerves or movement that would make a physical examination difficult (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Rebecca Kruse-Jarres, MD, MPH, Washington Institute for Coagulation
Phone: 206-614-1200
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
joint health comparison
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.